A primary metabolite of MAM2201, a synthetic cannabinoid commonly found in a variety of black market drug products marketed as herbal smoking blends. This stable-labeled internal standard is suitable for quantitation of MAM2201 4-hydroxypentyl metabolite levels in GC/MS or LC/MS synthetic cannabinoid testing methods for forensic analysis, clinical toxicology, and urine drug testing applications.
For those synthetic cannabinoids currently controlled at the federal level, our certified solution standards of these substances are DEA-exempt, allowing laboratories to place orders without additional regulatory paperwork. For US customers, state specific regulatory requirements may apply.